Dimitri Daldegan-Bueno

school of pharmacy, university of auckland, auckland, new zealand

H指数:14

被引数:704

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trial

微剂量使用LSD治疗抑郁症的感受是怎样的？——一项开放式标签试验中参与者访谈的主题分析

Therapeutic Advances in Psychopharmacology

IF4

2025-12-040

LSD microdosing in major depressive disorder: results from an open-label trial

LSD微剂量疗法在重度抑郁症中的应用：一项开放标签试验的结果

Neuropharmacology

IF4.6

2025-11-050

OAAI

Qualitative Content Analysis of Expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures

抑郁症患者开始LSD微剂量治疗前的期望定性内容分析：识别对致幻剂期望测量的需求

Neuropharmacology

IF4.6

2025-08-300

PREAI

OAV and 5D-ASC for Brazilian Portuguese: A validation and adaptation study

OAV和5D-ASC用于巴西葡萄牙语：一项验证和适应性研究

Journal of Psychopharmacology

IF5.5

2025-06-280

PRE

The association between cocaine product use and violence outcomes in Brazil: A comprehensive, systematized review

AGGRESSION AND VIOLENT BEHAVIOR

IF3.4

2024-01-013

PRE

The subiculum role on learning and memory tasks using rats and mice: A scoping review

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

IF7.9

2023-12-011

PRE

The current state of ayahuasca research in animal models: A systematic review

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2023-07-017

OAAI

LSD and language: Decreased structural connectivity, increased semantic similarity, changed vocabulary in healthy individuals

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2023-03-012

PRE

Ayahuasca?s therapeutic potential: What we know-and what not

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2023-01-0118

PRE

Cannabis use, risk behaviours and harms in Brazil: A comprehensive review of available data indicators

DRUG AND ALCOHOL REVIEW

IF2.6

2022-11-281

PRE

Identifying risk-thresholds for the association between frequency of cannabis use and development of cannabis use disorder: A systematic review and meta-analysis

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2022-09-0134

PRE

Ayahuasca and tobacco smoking cessation: results from an online survey in Brazil

PSYCHOPHARMACOLOGY

IF3.3

2022-02-1815

PRE

LSD and creativity: Increased novelty and symbolic thinking, decreased utility and convergent thinking

JOURNAL OF PSYCHOPHARMACOLOGY

IF5.5

2022-02-0120

Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies

PSYCHOPHARMACOLOGY

IF3.3

2021-10-067

OAAI

Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studies

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2021-10-0112

OAAI

'Resurgent', 'twin' or 'silent' epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America

SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY

IF3.2

2021-02-1538

OAAI

Opioid use, regulation, and harms in Brazil: a comprehensive narrative overview of available data and indicators

SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY

IF3.2

2021-01-2615

OAAI

Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, options and considerations

DRUG AND ALCOHOL REVIEW

IF2.6

2020-05-2015

OAAI

Dimitri Daldegan-Bueno

个人简介

教育背景

工作经历

荣誉奖项

研究方向